Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.980
-0.002 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sunshine Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -5.98 | -5.13 | -4.51 | -26.74 | -12.44 | Upgrade
|
| Depreciation & Amortization | 0.33 | 0.22 | 0.15 | 0.03 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.75 | - | - | 18.33 | - | Upgrade
|
| Stock-Based Compensation | - | 0.01 | - | - | 0.92 | Upgrade
|
| Other Operating Activities | 0.01 | - | - | -0.01 | 9.79 | Upgrade
|
| Change in Accounts Receivable | -0.12 | -2.34 | -0.59 | -0.52 | -0.01 | Upgrade
|
| Change in Inventory | -1.64 | -6.01 | -2.37 | 0.04 | -0.08 | Upgrade
|
| Change in Accounts Payable | -0.19 | 3.98 | -1.36 | 3.36 | -0.02 | Upgrade
|
| Change in Income Taxes | - | -0.81 | -0.07 | 0.24 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.5 | -2.45 | -0.02 | 0.03 | -0 | Upgrade
|
| Operating Cash Flow | -5.33 | -12.52 | -8.78 | -5.25 | -1.83 | Upgrade
|
| Capital Expenditures | -0.17 | -1.66 | -0.08 | -0.19 | - | Upgrade
|
| Cash Acquisitions | - | - | - | -14.35 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.66 | -0.32 | -0.71 | -0.11 | - | Upgrade
|
| Other Investing Activities | - | - | 0.13 | 0.03 | - | Upgrade
|
| Investing Cash Flow | -0.84 | -1.98 | -0.66 | -14.62 | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3.32 | Upgrade
|
| Total Debt Issued | - | - | - | - | 3.32 | Upgrade
|
| Long-Term Debt Repaid | - | - | -0.13 | -1.93 | -0.48 | Upgrade
|
| Total Debt Repaid | - | - | -0.13 | -1.93 | -0.48 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -0.13 | -1.93 | 2.84 | Upgrade
|
| Issuance of Common Stock | 4.75 | 12.08 | 4.09 | 43.56 | - | Upgrade
|
| Repurchase of Common Stock | - | -3.14 | -0.54 | -0.1 | - | Upgrade
|
| Other Financing Activities | - | - | - | -2.06 | 0.06 | Upgrade
|
| Financing Cash Flow | 4.75 | 8.94 | 3.43 | 39.47 | 2.9 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.86 | -1.04 | 0.47 | 0.18 | -0.02 | Upgrade
|
| Net Cash Flow | -0.56 | -6.61 | -5.53 | 19.78 | 1.06 | Upgrade
|
| Free Cash Flow | -5.51 | -14.18 | -8.86 | -5.44 | -1.83 | Upgrade
|
| Free Cash Flow Margin | -15.16% | -40.67% | -36.76% | -125.24% | -800.75% | Upgrade
|
| Free Cash Flow Per Share | -1.32 | -20.21 | -690.63 | - | - | Upgrade
|
| Cash Interest Paid | - | 0.01 | - | 0.05 | 0.04 | Upgrade
|
| Cash Income Tax Paid | - | 0.58 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -4.63 | -12.39 | -8.2 | -4.35 | -0.91 | Upgrade
|
| Unlevered Free Cash Flow | -4.63 | -12.38 | -8.12 | -4.33 | -0.7 | Upgrade
|
| Change in Working Capital | -1.45 | -7.63 | -4.42 | 3.15 | -0.11 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.